We deliver diagnostic data when it’s needed–when the patient is with the doctor
In an age when information can be transmitted at the speed of light, physicians and patients should be able to expect reliable bloodwork results within minutes of a test being completed. Leaving a A patient in limbo waiting days for results while test samples are shipped across the country is an unacceptable standard in the 21st century. Rapid test results that allow physicians to confidently make data-driven treatment decisions during a patients office visit should become the new standard of care.
Genalyte is making this new standard a reality, merging silicon biosensor technology and established biological techniques to empower doctors and patients alike. By moving data – not blood — we will help the physicians improve patient lives by providing test results when they matter: now.
Genalyteas platform quantifies the binding of biomolecules (antibodies, proteins, etc.) to silicon photonic biosensors. These biosensors function by detecting the changes in interaction between light circulating inside the sensor and matter deposited on the sensor surface.A Many microscopic biosensors can be lithographically printed on a single disposable silicon chip making multi-analyte panels of tests possible.A Leveraging existing state of the art silicon chip fabrication infrastructure brings attractive economies of scale for commercial production.
Our leadership team is drawn from the life sciences, diagnostics, and silicon chip fabrication industries. Decades of combined experience and diverse backgrounds make them uniquely qualified to bring the Genalyte technology to market and address the current and growing needs for rapid laboratory testing.